Who is sponsoring NCT03799991?

NCT03799991 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT03799991?

Interventions in NCT03799991: Vestibular physical therapy, Active control.

What condition does NCT03799991 study?

NCT03799991 studies Vestibular Diseases, Vestibular Disorder, Alzheimer Disease.

Is NCT03799991 still recruiting?

NCT03799991 is currently recruiting now. Last updated 12 January 2026.

Last reviewed 2026-01-12 · How we verify

NCT03799991

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vestibular Therapy in Alzheimer's Disease

Recruiting now NA Last updated 12 January 2026

What this trial tests

NA trial testing Vestibular physical therapy in Vestibular Diseases in 100 participants. Currently enrolling.

Timeline

22 August 2022

Primary endpoint
26 August 2027

26 August 2027

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	100
Start date	22 August 2022
Primary completion	26 August 2027
Estimated completion	26 August 2027
Sites	1 location across United States

Drugs / interventions tested

Vestibular physical therapy
Active control — full drug profile →

Conditions studied

Vestibular Diseases — all drugs for Vestibular Diseases →
Vestibular Disorder — all drugs for Vestibular Disorder →
Alzheimer Disease — all drugs for Alzheimer Disease →

Sponsor

Johns Hopkins University

Who can join

60 and older, any sex, with Vestibular Diseases or Vestibular Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nearly 2 out of 3 patients with Alzheimer's disease (AD) experience problems with balance and mobility, which places such patients at increased risk of falling. The vestibular (inner ear balance) system plays an important role in balance stability, and vestibular therapy (VT) is well-known to improve balance function in healthy older adults. In this study, the investigators will conduct a first-in-kind randomized clinical trial to evaluate whether vestibular therapy improves reduces falls in patients with AD, in whom this treatment has never been studied.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Vestibular therapy to reduce falls in people with Alzheimer's disease: study protocol for a pilot randomized controlled trial.
Yesantharao LV, Rosenberg P, Oh E, Leoutsakos J, et al · · 2022 · cited 5× · PMID 35918757 · DOI 10.1186/s40814-022-01133-w
Comparison of digital recruitment strategies for Alzheimer's disease patients.
Perez-Heydrich C, Walker C, Pile M, Agrawal Y. · · 2024 · cited 1× · PMID 38282922 · DOI 10.1177/20552076241229164

Verify or expand the search:

Other recruiting trials for Vestibular Diseases

Currently open trials in the same condition.

NCT05676944 — Vestibular Implantation in Older Adults · NA · recruiting
NCT05674786 — Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction · NA · recruiting
NCT05634902 — Implementation of Evidence-Based Practice for Dizziness · NA · active not recruiting
NCT03716908 — Genotype-phenotype Correlation Study of Presymptomatic and Symptomatic DFNA9 Patients · recruiting

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03799991 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 12 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03799991.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing